⌕

Ameriprise Financial (AMP) vs Royalty Pharma (RPRX)

Your goal
● Balanced style: every factor counts equally.
#1 FIT · LEADS
59
Royalty Pharma plc
$69.31 · $40B · as of last close
Best incomeCalmest rideHighest quality
of the stocks compared here

The front-runner. Leads the balanced score. Its widest win over the field is dividend & income.

#2 FIT
55
Ameriprise Financial Inc
$519.43 · $45B · as of last close
Fastest growerCheapestStreet favorite
of the stocks compared here

The challenger. Trails the leader on the balanced score. Its widest win over the field is growth.

RPRX barely leads (59/100 vs AMP 55) under a balanced style, mostly on dividend & income. But AMP wins on growth, so the comparison turns on what you weight. Switch your goal above and watch the scores move.

THE SCORECARD · FACTOR BY FACTOR · the best value in each row is ticked, and a tie ticks every tied column · weight bar shows how much it counts for your goal

FactorAMPRPRX
Overall fit score
weighted for your balanced goal
55
✓ 59
Valuation
Cheaper for what you get
1×
✓ P/E 11 · EV/EBITDA 7.9
P/E trailing
65
P/E 57
P/E trailing
32
Growth
Revenue & earnings momentum
1×
✓ —
56
—
14
Profitability & quality
Margins & return on capital
1×
Net 21% · ROIC 38%
TTM through Sep 30, 2026
58
✓ Net 45% · ROIC 8%
TTM through Sep 30, 2026
68
Total return
Share-price change with dividends reinvested
1×
5Y +13%/yr
68
✓ 5Y +15%/yr
77
Risk (calm = better)
Volatility & drawdown
1×
β 1.0 · DD −32%
66
✓ β 0.3 · DD −42%
95
Balance sheet†
Debt vs cash cushion
1×
Net debt/EBITDA −0.7×
TTM through Sep 30, 2026
25
✓ Current ratio 1.29
Sep 30, 2026 balance sheet
26
Dividend & income
Cash paid to you
1×
1.29% yield· A
33
✓ 1.36% yield· C
92
Analyst sentiment
Forward EPS growth (consensus)
1×
✓ Est EPS +12%/yr · 7 analysts
68
Est EPS +10%/yr · 4 analysts
64
† Balance sheet is scored on 5 peer percentiles (current ratio, quick ratio, net debt/EBITDA, interest coverage and debt/equity). The cell shows one of them, so a column can lead on the printed number and still lose the row.
The letter beside the dividend yield is our dividend-safety grade (A+ to F), a read on how likely that dividend is to be cut. It does not grade the yield.
Loading chart…
WHERE EACH ONE IS STRONG
GrowthValueQualityReturnSafetyIncome
■ AMP■ RPRX
CAN YOU STOMACH THE RIDE?
Worst drawdown3-year beta vs S&P 500VolatilityHistory
AMP−32%0.9828%5Y
RPRX−42%0.2524%5Y
Drawdown and volatility are measured over five years on the same total return as the chart, dividends reinvested.
THE CASE FOR & AGAINST EACH
BULL CASE

▲ Leads on growth: — (score 56).

▲ Leads on valuation: P/E 11 · EV/EBITDA 7.9 (score 65).

BEAR CASE

▼ Weakest on dividend & income: 1.29% yield (score 33).

▼ Weakest on risk (calm = better): β 1.0 · DD −32% (score 66).

BULL CASE

▲ Leads on dividend & income: 1.36% yield (score 92).

▲ Leads on risk (calm = better): β 0.3 · DD −42% (score 95).

BEAR CASE

▼ Weakest on growth: — (score 14).

▼ Weakest on valuation: P/E 57 (score 32).

WHAT COULD CHANGE THE SCORE
Balance sheetCurrently 25/100 (Net debt/EBITDA −0.7×). Taking it to 100 would lift the balanced score by 9 points, the biggest single move available.
Dividend & incomeCurrently 33/100 (1.29% yield). Taking it to 100 would lift the balanced score by 8 points, the next biggest.
GrowthCurrently 14/100 (—). Taking it to 100 would lift the balanced score by 10 points, the biggest single move available.
Balance sheetCurrently 26/100 (Current ratio 1.29). Taking it to 100 would lift the balanced score by 9 points, the next biggest.
Scores are Tenet composites, 0–100, reweighted for your selected goal. Seven of the eight factors are sector percentiles; analyst sentiment is an absolute curve on forward EPS growth, capped at 100, so two very high-growth names can share the top score. Moat/durability is not scored (qualitative, not measurable). Comparison is decision-support, not a recommendation · past performance does not predict future returns · Not investment advice · prices are each company's own latest close, the newest here being Nov 13, 2026 · valuation, growth, quality and balance scores from the Nov 13, 2026 scoring run · analyst consensus, return, risk and income scores computed Nov 13, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.